Zoledronate in the treatment of Paget's disease.
Siris
E
E
Department of Medicine, Columbia University, Columbia Presbyterian Hospital, New York 10032, USA.
D000368:Aged; D000469:Alkaline Phosphatase / Q000378:metabolism; D000596:Amino Acids / Q000652:urine; D001842:Bone and Bones / Q000201:enzymology; D002986:Clinical Trials as Topic; D003401:Creatine / Q000652:urine; D004164:Diphosphonates / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D006909:Hydroxyproline / Q000652:urine; D007093:Imidazoles / Q000627:therapeutic use*; D008297:Male; D010001:Osteitis Deformans / Q000188:drug therapy* / Q000201:enzymology / Q000652:urine; D000077211:Zoledronic Acid
D000596:Amino Acids; D004164:Diphosphonates; D007093:Imidazoles; D000077211:Zoledronic Acid; C036020:deoxypyridinoline; D000469:Alkaline Phosphatase; D003401:Creatine; D006909:Hydroxyproline